Patiromer Suppliers & Bulk Manufacturers

Available Forms: Sachet

Available Strengths: 8.4 mg

Reference Brands: Veltassa®(US) Generics

Category: Nephrology

Patiromer 8.4 g Sachet is used to treat hyperkalemia in patients with chronic kidney disease (CKD) or those on RAAS inhibitors. It helps lower elevated potassium levels by binding to potassium in the gastrointestinal tract, reducing the risk of cardiovascular complications. Patiromer is available in Sachet and strengths such as 8.4 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Patiromer is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Patiromer can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Patiromer 8.4 g Sachet is a key treatment in nephrology for managing hyperkalemia in patients with chronic kidney disease (CKD) or those on RAAS inhibitors. This potassium-binding medication helps lower elevated potassium levels in the blood, reducing the risk of cardiovascular complications. Available in a convenient 8.4 g sachet form, Patiromer is widely used in hospital and clinical settings across the US and EU. For pharma B2B in these regions, it provides a reliable solution for healthcare providers managing electrolyte imbalances in high-risk patients. Patiromer’s efficacy and safety make it an essential product in nephrology care.